Versant Capital Management’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-3,838
Closed -$3K 1723
2022
Q2
$3K Hold
3,838
﹤0.01% 1050
2022
Q1
$5K Sell
3,838
-2,864
-43% -$2.64K ﹤0.01% 912
2021
Q4
$9K Buy
6,702
+5,514
+464% +$9.86K ﹤0.01% 743
2021
Q3
$3K Sell
1,188
-325
-21% -$888 ﹤0.01% 1084
2021
Q2
$6K Sell
1,513
-2,404
-61% -$8.35K ﹤0.01% 871
2021
Q1
$13K Sell
3,917
-310
-7% -$1.11K ﹤0.01% 714
2020
Q4
$14K Hold
4,227
0.01% 640
2020
Q3
$17K Sell
4,227
-102
-2% -$388 0.01% 490
2020
Q2
$14K Buy
4,329
+114
+3% +$332 0.01% 537
2020
Q1
$9K Buy
+4,215
New +$11.5K ﹤0.01% 600
2019
Q3
Sell
-235
Closed -$2K 1657
2019
Q2
$2K Sell
235
-227
-49% -$2.03K ﹤0.01% 1229
2019
Q1
$4K Sell
462
-1,284
-74% -$13.8K ﹤0.01% 1206
2018
Q4
$15K Sell
1,746
-7
-0.4% -$89 0.01% 668
2018
Q3
$29K Sell
1,753
-106
-6% -$2.29K 0.01% 472
2018
Q2
$38K Sell
1,859
-466
-20% -$8.63K 0.02% 387
2018
Q1
$37K Sell
2,325
-270
-10% -$5.35K 0.02% 394
2017
Q4
$49K Buy
2,595
+1,103
+74% +$20K 0.02% 309
2017
Q3
$20K Buy
1,492
+713
+92% +$6.45K 0.01% 596
2017
Q2
$5K Buy
779
+340
+77% +$2.22K ﹤0.01% 1073
2017
Q1
$2K Buy
439
+391
+815% +$2.19K ﹤0.01% 1286
2016
Q4
$0 Buy
+48
New +$201 ﹤0.01% 1574
2016
Q3
Sell
-292
Closed -$1K 1528
2016
Q2
$1K Buy
292
+85
+41% +$601 ﹤0.01% 1301
2016
Q1
$1K Buy
207
+131
+172% +$672 ﹤0.01% 1298
2015
Q4
$0 Buy
+76
New +$435 ﹤0.01% 1447

Other funds holding SPPI

Versant Capital Management's SPPI Position: Q3 2022 in Review

Versant Capital Management sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2022, closing a stake of 3,838 shares — an estimated $3K sold.

Versant Capital Management first reported a position in SPPI in Q4 2015 and held it in 24 quarters. The position peaked at $49K in Q4 2017. 75 funds tracked by Wall St. Rank hold SPPI as of Q3 2022.

  • Versant Capital Management reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2022 after selling out during the quarter.
  • Versant Capital Management sold 3,838 Spectrum Pharmaceuticals Inc shares in Q3 2022, an estimated $3K.
  • Versant Capital Management first reported a position in Spectrum Pharmaceuticals Inc in Q4 2015 and held it in 24 quarters.
  • Versant Capital Management's Spectrum Pharmaceuticals Inc position peaked at $49K in Q4 2017.
  • 75 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2022.

Based on Versant Capital Management's 13F filing for Q3 2022, filed 30 Dec 2022.